Clinical profile and etiological evaluation of new onset focal seizure in adults

2019 ◽  
Vol 12 (3) ◽  
pp. 69-73
Author(s):  
Sachin S Bangar ◽  
◽  
Akshay B Shinde ◽  
Keyword(s):  
Focal Seizure ◽  
Clinical Profile ◽  
New Onset

scholarly journals New Onset Diabetes after Transplant – Risk Factors, Clinical Profile and Outcome

2018 ◽  
Vol 2 (1) ◽  
pp. 35-40
Author(s):  
Sakthirajan R ◽  
Dhanapriya J ◽  
Dineshkumar T ◽  
Balasubramaniyan T ◽  
Gopalakrishnan N ◽  
...  
Keyword(s):  
Risk Factors ◽  
Insulin Resistance ◽  
Family History ◽  
Fasting Blood Glucose ◽  
Hcv Infection ◽  
Clinical Profile ◽  
Family History Of Diabetes ◽  
Onset Diabetes ◽  
History Of ◽  
New Onset

Background: New onset diabetes after transplant (NODAT) remains one among the significant threats to both renal allograft and patient survival. The aim of this study was to analyse the clinical profile and risk factors for NODAT.Methods: This prospective observational study involved patients who underwent renal transplantation in our centre between 2010 and 2015.Results: During the mean follow up period of 18 ± 6 months, incidence of NODAT was 26.6% and the cumulativeincidence was highest in the first year after transplant. Recipient age, pre transplant impaired fasting glucose, Hepatitis C virus (HCV) infection, family history of diabetes, tacrolimus, post transplant hypertriglyceridemia and metabolic syndrome were found to be statistically significant risk factors for NODAT. In Cox multivariate regression analysis, age and family history of diabetes were found to be independent risk factors for NODAT. Fasting C-peptide level underlines insulin resistance as predominant mechanism for NODAT in two third of patients. There were higher incidence of urinary tract infection in the NODAT patients. NODAT was found to be an independent risk factor for fungal infection and 10 year cardiovascular risk in the renal recipients. There was no significant impact of NODAT on short term graft and patient survival.Conclusion: Age, pre-transplant fasting blood glucose, family history of diabetes, HCV infection and tacrolimus were found to be the important risk factors, with insulin resistance as the predominant mechanism for NODAT.

scholarly journals New Onset Focal Seizure Following COVID-19 Vaccination: Case Report

2021 ◽  
Author(s):  
Chun Seng Phua ◽  
Shalini Bhaskar ◽  
Azman Ali Raymond
Keyword(s):  
Case Report ◽  
Side Effects ◽  
Focal Seizure ◽  
Seizure Threshold ◽  
Hippocampal Atrophy ◽  
Case Presentation ◽  
Mri Brain ◽  
Focal Seizures ◽  
Patient’S History ◽  
New Onset

Abstract IntroductionAs more novel COVID-19 vaccines are being rolled out in a frantic pace globally, any complication that might be related to COVID-19 vaccines should be highlighted, especially since COVID-19 vaccines are relatively new, and side effects may yet to be fully elucidated. We report a case of a healthy 18-year-old male who presented with new onset focal seizures 5 days after receiving 1st dose of Oxford/AstraZeneca COVID-19 vaccine. Case PresentationThe patient was treated with intravenous phenytoin and oral levetiracetam 250mg twice daily with no further events. There was no documented fever. CT venogram and EEG were unremarkable. MRI brain revealed generalised atrophy including mild bilateral hippocampal atrophy with no evidence of sclerosis. There was no predilection for seizures identified from the patient’s history. The patient was discharged the following day on levetiracetam and advised to proceed with the 2nd dose of Oxford/AstraZeneca COVID-19 vaccination in 3 months’ time.ConclusionSeizures following COVID-19 vaccination have only been reported in a handful of cases. COVID-19 vaccination could lower seizure threshold, or unmask an underlying predisposition for epilepsy. As most COVID-19 vaccines worldwide are given in 2 doses, clinicians should consider maintaining patients on anti-seizure drugs if vaccination was thought to be a provoking factor.

Dementia, Subtype of Seizures, and the Risk of New Onset Seizures: A Cohort Study of a National U.S. Managed Care Database

2021 ◽  
pp. 1-8
Author(s):  
Miguel E. Habeych ◽  
Tatiana Falcone ◽  
Anjali Dagar ◽  
Lisa Ford ◽  
Ruby Castilla-Puentes
Keyword(s):  
Focal Seizure ◽  
Group Differences ◽  
Dementia Diagnosis ◽  
Chi Square ◽  
Seizure Disorders ◽  
Hazard Ratios ◽  
Grand Mal ◽  
Care Database ◽  
Insured Patient ◽  
New Onset

Background: Seizure disorders have been identified in patients suffering from different types of dementia. However, the risks associated with the seizure subtypes have not been characterized. Objective: To compare the occurrence and risk of various seizure subtypes (focal and generalized) between patients with and without a dementia diagnosis. Methods: Data from 40.7 million private insured patient individual electronic health records from the U.S., were utilized. Patients 60 years of age or more from the Optum Insight Clinformatics-data Mart database were included in this study. Using ICD-9 diagnoses, the occurrence of generalized or focal seizure disorders was identified. The risk of new-onset seizures and the types of seizures associated with a dementia diagnosis were estimated in a cohort of 2,885,336 patients followed from 2005 to 2014. Group differences were analyzed using continuity-adjusted chi-square and hazard ratios with 95%confidence intervals calculated after a logistic regression analysis Results: A total of 79,561 patient records had a dementia diagnosis, and 56.38%of them were females. Patients with dementia when compared to those without dementia had higher risk for seizure disorders [Hazard ratio (HR) = 6.5 95%CI = 4.4–9.5]; grand mal status (HR = 6.5, 95%CI = 5.7–7.3); focal seizures (HR = 6.0, 95%CI = 5.5–6.6); motor simple focal status (HR = 5.6, 95%CI = 3.5–9.0); epilepsy (HR = 5.0, 95%CI = 4.8–5.2); generalized convulsive epilepsy (HR = 4.8, 95%CI = 4.5–5.0); localization-related epilepsy (HR = 4.5, 95%CI = 4.1–4.9); focal status (HR = 4.2, 95%CI = 2.9–6.1); and fits convulsions (HR = 3.5, 95%CI = 3.4–3.6). Conclusion: The study confirms that patients with dementia have higher risks of generalized or focal seizure than patients without dementia.

scholarly journals Clinical profile and neurodevelopmental outcome of new-onset acute symptomatic seizures in children

Seizure ◽  
2017 ◽  
Vol 50 ◽  
pp. 130-136 ◽  
Author(s):  
Vimlesh Soni ◽  
Pratibha Singhi ◽  
Arushi Gahlot Saini ◽  
Prabhjot Malhi ◽  
Radha K. Ratho ◽  
...  
Keyword(s):  
Neurodevelopmental Outcome ◽  
Clinical Profile ◽  
Symptomatic Seizures ◽  
Acute Symptomatic Seizures ◽  
New Onset

scholarly journals Clinical profile, outcome and risk factors of new onset of diabetes after renal transplantation

2016 ◽  
Vol 10 (4) ◽  
pp. 101-102
Author(s):  
Sabarinathc ◽  
Jacob George ◽  
M.K. Mohandas ◽  
Sajeevkumar ◽  
Noble Gracious ◽  
...  
Keyword(s):  
Risk Factors ◽  
Renal Transplantation ◽  
Clinical Profile ◽  
Onset Of Diabetes ◽  
New Onset

scholarly journals Giant intracranial calcification associated with new onset focal seizure

2013 ◽  
Vol 2013 (sep07 1) ◽  
pp. bcr2013010514-bcr2013010514
Author(s):  
P. P. Jankowski ◽  
D. M. Malicki ◽  
M. L. Levy ◽  
J. R. Crawford
Keyword(s):  
Focal Seizure ◽  
Intracranial Calcification ◽  
New Onset
Sign in / Sign up

Export Citation Format

Share Document